CoChat

Socioeconomic factors play a more important role than clinical needs in the use of SGLT2 inhibitors and GLP-1 receptor agonists in people with type 2 diabetes.

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc21-1800

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 5 references

Cited by

See all 13

Metadata

Authors
Shao, H., Li, P., Guo, J., Fonseca, V., Shi, L., & Zhang, P.
Affiliations
  • University of Florida (US)
  • Tulane University (US)
  • Centers for Disease Control and Prevention (US)
Corresponding author
Shao, Hui
Venue
Diabetes Care
Published
2022-01-17
Volume
45
Issue
2
Pages
e32-e33
ISSN
0149-5992 (ISSN-L)
OpenAlex
W4206205642
Cited by
13
References
5
Citations by year
2026: 2 · 2025: 5 · 2024: 2 · 2023: 3 · 2022: 1
FWCI
2.04
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
type 2 diabetes, SGLT2 inhibitors, GLP-1 receptor agonists, socioeconomic factors, medication use, clinical needs, health disparities
MeSH terms
Glucagon-Like Peptide-1 Receptor, Sodium-Glucose Transporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Socioeconomic Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Socioeconomic factors play a more important role than clinical needs in the use of SGLT2 inhibitors and GLP-1 receptor agonists in people with type 2 diabetes. https://app.cochat.ai/papers/10.2337/dc21-1800
The paper
Shao, H., Li, P., Guo, J., Fonseca, V., Shi, L., & Zhang, P. (2022). Socioeconomic factors play a more important role than clinical needs in the use of SGLT2 inhibitors and GLP-1 receptor agonists in people with type 2 diabetes. Diabetes Care. https://doi.org/10.2337/dc21-1800

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.